News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best biotech stocks to invest in now. On June 20, Vertex ...
Researchers given funding to explore stem cell-based approaches for cystic fibrosis-related diabetes
Researchers from the University of Birmingham have been awarded a £300,000 Development Award from the Cystic Fibrosis Trust to explore whether stem cell derived islet cell transplants could offer a ...
Researchers investigated the association between the presence of concurrent metabolic comorbidities and the severity of liver fibrosis in 3179 patients with untreated chronic hepatitis B (median ...
Six out of 10 people with type 2 diabetes had fatty liver in a new study from Linköping University. Of these, only a small percentage had developed more severe liver disease.
Over-the-counter supplement could prevent heart disease in type 2 diabetes patients - Medical Xpress
A cheap over-the-counter supplement could hold the key to preventing heart failure in people with Type 2 diabetes, according to research presented Tuesday at the British Cardiovascular Society ...
Avoid peak sun hours. In many areas, this is between the hours of 10 a.m. and 3 p.m. Opt for early morning or evening activities to avoid the worst of the heat.
And in between the diabetes medicines, there comes faith through a temple in South India. Located in Tamil Nadu, the Venni Karumbeswarar Temple is over a thousand years old, and is dedicated to ...
In collaboration with Eli Lilly and Company (NYSE:LLY), a pharmaceutical company recognized globally for its innovative diabetes and metabolic therapies, Nxera Pharma has reached a key development ...
Over three years of follow-up between 2020 and 2023, 0.2% (93 patients) of those in the GLP-1 user group were diagnosed with nAMD, as were 0.1% (88 patients) in the contrasting group.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results